Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Chembio Diagnostics, Inc.

Chembio Diagnostics, Inc. (CEMI) Stock Overview

Explore Chembio Diagnostics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

CEMI●NASDAQ
HealthcareMedical - Diagnostics & Research
$0.46
$0.001(0.22%)
U.S. Market opens in 12h 45m

Chembio Diagnostics, Inc. (CEMI)

Meyka AI Score

Z

Key Financials

Market Cap16.7M
P/E Ratio-0.47
EPS (TTM)$-0.72
ROE-0.89%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

CEMI Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Chembio Diagnostics, Inc. (NASDAQ: CEMI) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Chembio Diagnostics, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of CEMI on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind Chembio Diagnostics, Inc.'s NASDAQ-traded stock include a P/E ratio of -0.47 and a market capitalization of 16.7M. Combined with our AI analysis, these give both institutional and retail investors a clear view of CEMI on the NASDAQ.

Price Performance (NASDAQ: CEMI)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
1.56%
6-Month Change
42.41%
Year-to-Date (YTD) Change
80.20%
1-Year Change
-32.55%
3-Year Change
-95.35%
5-Year Change
-95.24%
All-Time (Max) Change
-99.98%

Contact Information

https://chembio.com
631 924 1135
555 Wireless Boulevard, Hauppauge, NY, 11788

Company Facts

1,880 Employees
IPO DateOct 18, 2000
CountryUS

Frequently Asked Questions